Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-6 of 6

Sort by

Sort Order Select

Journal Articles

IHP-102 reduces pain and modulates complement activation in a sickle cell mouse model

Kennedy Goldsborough, Srija Ponna, Ronake Desai, Ashwin Patel, John Paderi, Vivien Sheehan

Blood (2025) 146 (Supplement 1): 4710.

https://doi.org/10.1182/blood-2025-4710

Published: 2025

Journal Articles

IHP-102 compound decreases the adhesion of sickle cell disease RBCs to acutely activated endothelial cells in biochip labs endothelial-on-a-chip assay

Chiara Federici, Samantha Braxton, Ahmad Dakhlallah, Victoria Buskey, Jesus Candler, John Zak, Gabriel Njikang, John Paderi, Umut Gurkan

Blood (2025) 146 (Supplement 1): 4708.

https://doi.org/10.1182/blood-2025-4708

Published: 2025

Journal Articles

Dual complement and P-selectin inhibitor, IHP-102, prevents lung vaso-occlusion in P-selectin-deficient townes SS mice

John Paderi, Rikesh Dubey, Tomasz Kaminski, Fnu Manikanta, Prithu Sundd

Blood (2025) 146 (Supplement 1): 4707.

https://doi.org/10.1182/blood-2025-4707

Published: 2025

Journal Articles

IHP-102 Reduces Hypoxia-Induced Pain Behaviors in Townes SCD Mice

Kennedy N Goldsborough, Israel Almeida, Ashwin P. Patel, John Paderi, Vivien Sheehan

Blood (2024) 144 (Supplement 1): 1106.

https://doi.org/10.1182/blood-2024-210418

Published: 2024

Journal Articles

Dual P-Selectin and Complement Inhibition with Subcutaneous IHP-102 Treatment Potently Reduces Lung Vaso-Occlusion in Sickle Cell Disease Mice

John Paderi, Rikesh K Dubey, Gabriel Njikang, Prithu Sundd

Blood (2023) 142 (Supplement 1): 1122.

https://doi.org/10.1182/blood-2023-174796

Published: 2023

Journal Articles

Subcutaneous Injection of IHP-102 Attenuates Lung Vaso-Occlusion in Sickle Cell Disease Mice

Ravi Vats, Rikesh K Dubey, Gabriel Njikang, John Paderi, Prithu Sundd

Blood (2022) 140 (Supplement 1): 8238.

https://doi.org/10.1182/blood-2022-163516

Published: 2022

Update search

NARROW

Publications

Format

Article Type

Date

Availability

IHP-102 reduces pain and modulates complement activation in a sickle cell mouse model

IHP-102 compound decreases the adhesion of sickle cell disease RBCs to acutely activated endothelial cells in biochip labs endothelial-on-a-chip assay

Dual complement and P-selectin inhibitor, IHP-102, prevents lung vaso-occlusion in P-selectin-deficient townes SS mice

IHP-102 Reduces Hypoxia-Induced Pain Behaviors in Townes SCD Mice

Dual P-Selectin and Complement Inhibition with Subcutaneous IHP-102 Treatment Potently Reduces Lung Vaso-Occlusion in Sickle Cell Disease Mice

Subcutaneous Injection of IHP-102 Attenuates Lung Vaso-Occlusion in Sickle Cell Disease Mice

Email alerts

ASH Publications

American Society of Hematology

Update search

IHP-102 reduces pain and modulates complement activation in a sickle cell mouse model

IHP-102 compound decreases the adhesion of sickle cell disease RBCs to acutely activated endothelial cells in biochip labs endothelial-on-a-chip assay

Dual complement and P-selectin inhibitor, IHP-102, prevents lung vaso-occlusion in P-selectin-deficient townes SS mice

IHP-102 Reduces Hypoxia-Induced Pain Behaviors in Townes SCD Mice

Dual P-Selectin and Complement Inhibition with Subcutaneous IHP-102 Treatment Potently Reduces Lung Vaso-Occlusion in Sickle Cell Disease Mice

Subcutaneous Injection of IHP-102 Attenuates Lung Vaso-Occlusion in Sickle Cell Disease Mice

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only